1. Web alert

   News Pages: 48 - 48

2. Treatment of HCV infection with pegylated interferons

   • Graham R. Foster
   • Abid R. Suddle

   OriginalPaper Pages: 49 - 55

3. Management of hematologic side effects: Impact on compliance and efficacy

   • Furqaan Ahmed
   • Ira M. Jacobson

   OriginalPaper Pages: 56 - 60

4. Antifibrotic targets and therapy in HCV

   • Efsevia Albanis
   • Scott L. Friedman

   OriginalPaper Pages: 61 - 67

5. Antiviral therapy in the HCV-coinfected patient with HIV and/or HBV

   • James S. Park
   • Neeraj Saraf
   • Douglas T. Dieterich

   OriginalPaper Pages: 68 - 74

6. Antiviral therapy in the liver transplant candidate and recipient

   • Gregory T. Everson

   OriginalPaper Pages: 75 - 82